Section 32 Names Steven J. Kafka, Ph.D., as Managing Partner
Summary
SAN DIEGO--(BUSINESS WIRE)--Section 32, a venture capital fund investing at the frontiers of technology, healthcare and life sciences, announced today the appointment of Steven J. Kafka, Ph.D., as a managing partner. “Steve recognizes the revolutionary potential of the convergence of technology and healthcare, and its power to positively impact patients,” said Bill Maris, Founder of Section 32. “He is a proven company builder, with multi-decade relationships in Boston and the broader life science communities, which will benefit our team as we build our fund and partnership. “I am honored to join the amazing team at Section 32, and to expand our collective efforts to support innovation at the nexus of technology and healthcare,” said Steve. The fund backs curious and determined scientists, engineers, and designers who are tackling seemingly impossible-to-solve problems with a clear view on how the world should or will work.